CFTR modulator therapy drives microbiome restructuring through improved host physiology in cystic fibrosis: the IMMProveCF phase IV trial

Guardado en:

Detalles Bibliográficos
Publicado en:	Nature Communications vol. 16, no. 1 (2025), p. 10111-10127
Autor principal:	Knoll, Rebecca Luise
Otros Autores:	Brauny, Melanie Meihua, Robert, Evelyn, Cloos, Louisa, Waser, Lydia, Hilbert, Katja, Ulmer, Nina, Hillen, Barlo, Birkner, Till, Bartolomaeus, Theda Ulrike Patricia, Nitsche, Oliver, Jarquín-Díaz, Víctor Hugo, Lynch, Susan, Gehring, Stephan, Maier, Lisa, Poplawska, Krystyna, Forslund-Startceva, Sofia Kirke
Publicado:	Nature Publishing Group
Materias:	Physiology Cystic fibrosis transmembrane conductance regulator rRNA 16S Longitudinal studies Modulators Mutation Antibacterial activity Species diversity Gastrointestinal tract Inflammation Feces Cystic fibrosis Microbiomes Intestinal microflora Microorganisms Lungs Age Sputum Gene sequencing Species richness Antibiotics Respiratory function Dysbacteriosis Gut microbiota Genetic disorders Digestive system Escherichia Staphylococcus Environmental
Acceso en línea:	Citation/Abstract Full Text Full Text - PDF
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!